LISTE DES DERNIERS SEMINAIRES INVITES DE L’UNITE 

20/05/2019. Nizar, BAHLIS. (University of Calgary, Calgary, Canada). Single-cell profiling to guide precision medicine in multiple myeloma.

21/03/2019. Marie-Caroline, DIEU-NOSJEAN. (Centre d’Immunologie et des Maladies Infectieuses, Paris, France). Key cross-talk between tertiary lymphoid structures and its tumor microenvironment in lung cancer patients.

06/03/2019. Christophe, PAGET. (Centre d’Etudes des Pathologies Respiratoires (Inserm U1100), Tours, France). Mammalia ganglioside species with specific ceramide backbones activate invariant natural killer T cells.

14/02/2019. Vincent, GUEN. (Institut de Génétique et Développement de Rennes, Rennes, France). Un(MaSC)ing the ability of EMT programs to promote stemness by inducing primary ciliogenesis.

29/01/2019. Vincent, HYENNE. (Institut Immunologie-Hématologie, Strasbourg, France). Fate and function of tumor extracellular vesicles in vivo.

19/12/2018. Jean-Ehrland, RICCI. (C3M (Inserm U1065), Nice, France). Deciphering the link between metabolism and anti-cancer immunosurveillance.

21/11/2018. François, LEGOUX. (Institut Curie, Paris, France). Vitamin metabolites from the microbiota control thymic development of MAIT cells.

16/11/2018. Jean-Jacques, FOURNIE. (Centre de Recherche en Cancérologie de Toulouse, Toulouse, France). Single cell transcriptomics unveils the distinct cytotoxic profiles of human TCRVd1 and TCRVd2 gd T lymphocytes.

05/11/2018. Elisa, LANDAIS. (Scripps CA, Cincinnati, Etats-Unis). Development of Broadly Neutralizing Antibodies to HIV-1 : lessons from the IAVI Protocol C cohort.

18/10/2018. Cyrille, GRANDJEAN. (UMR CNRS 6286, Faculté des Sciences et Techniques, Nantes, France). Vers une nouvelle génération de vaccins glycoconjugués ; recrutement des lymphocytes T non conventionnels pour l’induction d’une réponse mémoire anti-sucre.

18/10/2018. Christophe, PAGET. (Inserm U1100 : Centre d’Etude des Pathologies Respiratoires (CEPR), Tours, France). Développement et ligands endogènes des lymphocytes NKT humains.

10/10/2018. Thierry, SOUSSI. (Université Pierre & Marie Curie et Karolinska Institute, Paris & Stockholm, France & Suède). Le gène suppresseur de tumeur TP53 : un aller-retour entre paillasse et clinique.

09/10/2018. Céline, FROCHOT. (Laboratoire Réactions et Génie des Procédés (CNRS, UMR 7274), Nancy, France). Anti-cancer photodynamic therapy: from bench to bedside.

21/09/2018. Corinne, ABBADIE. (Institut de Biologie (UMR 8161), Lille, France). A new role for DNA single-strand breaks in senescence and neoplastic escape.

20/09/2018. Adrien, BOSSEBOEUF. (University of New Mexico, UNM Department of pathology, Albuquerque, Etats-Unis). Infectious antigen-dependant BCR signalling.

21/06/2018. Marion, ESPELI. (Inserm UMR_S996, Université Paris-Sud, Clamart, France). Cxcr4 desensitization controls plasma cell differentiation and migration.

14/06/2018. Leo, JAMES. (MRC Laboratory of Molecular Biology, Cambridge, Angleterre). Trim-Away: Targeted Degradation of Pathogens and Proteins by the Cytosolic Antibody Receptor TRIM21.

14/06/2018. Zakia, DJAOUD. (Peter Parham, University School of Medicine, Stanford, Etats-Unis). Human genetic variations affecting innate immune responses to infections and cancer.

07/06/2018. Julien, DUEZ. (USR3151, Station Biologique, Roscoff, France). Pharmacological stiffening of cancer stem cells to prevent tumor dissemination.

06/06/2018. Florent, SEBBANE. (IBL – Institut Pasteur, Lille, France). New approach and insights into how yersinia pestis produces a transmissible infection in fleas.

24/05/2018. Marco, DEMARIA. (University of Groningen, Groningen, Pays Bas). Cellular senescence in cancer therapy: friend or foe ?.

15/03/2018. Gwendal, LAZENNEC. (Sys2diag, CNRS UMR 9005, Montpellier, France). Microenvironnement of tumor niches.

22/02/2018. Carl, HERRMANN. (IPMM – Universität Bioinformatik, Heidelberg, Allemagne). Deciphering programs of transcriptional regulation by combined deconvolution of multiple omics layers.

08/02/2018. Stéphane, RODRIGUEZ. (U917 – Microenvironnement et Cancer, Rennes, France). Follicular regulatory T cell characterization in Follicular Lymphoma.

06/02/2018. Gilles, UZE. (UMR 5235 CNRS – Dynamique des Interactions Membranaires Normales et Pathologiques, Montpellier, France). Ciblage cellulaire d’agonistes et d’antagonistes de l’interféron de type I : Applications possibles dans les stratégies thérapeutiques antitumorales.

01/02/2018. Mathilde, BONNET. (UMR 1071 Inserm – Microbes Intestin Inflammation et Susceptibilité de l’Hôte, Clermont-Ferrand, France). Microbes Intestin Inflammation et Susceptibilité de l’Hôte.

27/11/2017. Thierry, DEFRANCE. (CIRIC – Inserm U1111, Lyon, France). La plasmocyte lgM+ : un cas de dédoublement de la personnalité cellulaire.

19/10/2017. Irène, BACCELI. (IRIC, Montréal, Canada). Sans titre.

03/10/2017. Eric, ELDERING. (Academical Medical Center, Amsterdam, Pays Bas). Dissecting the role of Bcl-2 members in response and resistance to Ibrutinib or Venetoclax in Chronic Lymphocytic Leukemia.

26/09/2017. Geneviève, HERY-ARNAUD. (CHU Brest, Brest, France). Microbiote respiratoire : nouveau regard en santé pulmonaire.

13/09/2017. Sébastien, JAILLON. (Istitudo Clinico Humanitas – Research laboratory in Immunology & Inflammation, Milan, Italie). The role of neutrophils in cancer.

04/09/2017. Prasad, ADUSUMILLI. (Memorial Sloan-Ketterin Cancer Center, NewYork, Etats-Unis). Tummor Immunology ; CAR T cell therapy ; Combination  hemo/radiation + immunotherapy.

06/07/2017. Manuel, EHLING. (VIB-KU Leuven Center for Cancer Biology, Louvain, Belgique). Vessel normalisation and anti-angiogenic therapy.

13/04/2017. Fatima, MECHTA-GRIGORIOU. (Institut Curie – Inserm U830, Paris, France). Role of miR-200 and stromal heterogeneityin ovarian and breast tumours.

09/02/2017. Marc, DALOD. (Centre d’Immunologie de Marseille, Marseille, France). Investigating the role of XCR1+ dendritic cells in anti-tumor immunity.